{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:54:15Z","timestamp":1791359655347,"version":"4.3.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"41","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K02315"],"award-info":[{"award-number":["24K02315"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K19190"],"award-info":[{"award-number":["24K19190"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K15314"],"award-info":[{"award-number":["23K15314"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008886","name":"Princess Takamatsu Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["NIH R01 CA259188"],"award-info":[{"award-number":["NIH R01 CA259188"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA251674"],"award-info":[{"award-number":["R01 CA251674"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["ACS RSG-23-722314"],"award-info":[{"award-number":["ACS RSG-23-722314"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,10,28]]},"DOI":"10.1038\/s41388-026-03970-y","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:02:52Z","timestamp":1787637772000},"page":"4393-4405","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genome-wide CRISPR screens identify an RXR\u2013MYLIP\u2013LDLR axis regulating BH3 mimetic sensitivity in peripheral T-cell lymphomas"],"prefix":"10.1038","volume":"45","author":[{"given":"Keito","family":"Yokoyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2731-6091","authenticated-orcid":false,"given":"Masahiro","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Takei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8212-5664","authenticated-orcid":false,"given":"Keito","family":"Suto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall E.","family":"Kadin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiyuki","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9697-1810","authenticated-orcid":false,"given":"Masashi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2150-9979","authenticated-orcid":false,"given":"Shigetsugu","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0941-271X","authenticated-orcid":false,"given":"Takanori","family":"Teshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8602-6054","authenticated-orcid":false,"given":"Masao","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"3970_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41568-021-00407-4","volume":"22","author":"ST Diepstraten","year":"2022","unstructured":"Diepstraten ST, Anderson MA, Czabotar PE, Lessene G, Strasser A, Kelly GL. The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs. Nat Rev Cancer. 2022;22:45\u201364.","journal-title":"Nat Rev Cancer"},{"key":"3970_CR2","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1182\/blood-2018-07-865527","volume":"133","author":"R Koch","year":"2019","unstructured":"Koch R, Christie AL, Crombie JL, Palmer AC, Plana D, Shigemori K, et al. Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomas. Blood. 2019;133:566\u201375.","journal-title":"Blood"},{"key":"3970_CR3","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1182\/blood.2022015646","volume":"140","author":"M Chiba","year":"2022","unstructured":"Chiba M, Shimono J, Ishio T, Takei N, Kasahara K, Ogasawara R, et al. Genome-wide CRISPR screens identify CD48 defining susceptibility to NK cytotoxicity in peripheral T-cell lymphomas. Blood. 2022;140:1951\u201363.","journal-title":"Blood"},{"key":"3970_CR4","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1182\/blood.2021012734","volume":"139","author":"T Ishio","year":"2022","unstructured":"Ishio T, Kumar S, Shimono J, Daenthanasanmak A, Dubois S, Lin Y, et al. Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia\/lymphoma. Blood. 2022;139:1541\u201356.","journal-title":"Blood"},{"key":"3970_CR5","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1182\/blood.2023021423","volume":"143","author":"M Chiba","year":"2024","unstructured":"Chiba M, Shimono J, Suto K, Ishio T, Endo T, Goto H, et al. Whole-genome CRISPR screening identifies molecular mechanisms of PD-L1 expression in adult T-cell leukemia\/lymphoma. Blood. 2024;143:1379\u201390.","journal-title":"Blood"},{"key":"3970_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41375-024-02441-1","volume":"39","author":"K Suto","year":"2025","unstructured":"Suto K, Takei N, Yokoyama K, Chiba M, Ishio T, Maeda M, et al. Genome-wide CRISPR screen identifies MAD2L1BP and ANAPC15 as targets for brentuximab vedotin sensitivity in CD30+ peripheral T-cell lymphoma. Leukemia. 2025;39:243\u20137.","journal-title":"Leukemia"},{"key":"3970_CR7","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ccell.2018.06.014","volume":"34","author":"M Nakagawa","year":"2018","unstructured":"Nakagawa M, Shaffer AL 3rd, Ceribelli M, Zhang M, Wright G, et al. Targeting the HTLV-I-regulated BATF3\/IRF4 transcriptional network in adult T cell leukemia\/lymphoma. Cancer Cell. 2018;34:286\u201397.e210.","journal-title":"Cancer Cell"},{"key":"3970_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li W, Xu H, Xiao T, Cong L, Love MI, Zhang F, et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 2014;15:554.","journal-title":"Genome Biol"},{"key":"3970_CR9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2004.12.030","volume":"17","author":"L Chen","year":"2005","unstructured":"Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG, et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell. 2005;17:393\u2013403.","journal-title":"Mol Cell"},{"key":"3970_CR10","doi-asserted-by":"publisher","first-page":"D730","DOI":"10.1093\/nar\/gkae1113","volume":"53","author":"D Szklarczyk","year":"2025","unstructured":"Szklarczyk D, Nastou K, Koutrouli M, Kirsch R, Mehryary F, Hachilif R, et al. The STRING database in 2025: protein networks with directionality of regulation. Nucleic Acids Res. 2025;53:D730\u201337.","journal-title":"Nucleic Acids Res"},{"key":"3970_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14620-6","volume":"11","author":"PC DeWeirdt","year":"2020","unstructured":"DeWeirdt PC, Sangree AK, Hanna RE, Sanson KR, Hegde M, Strand C, et al. Genetic screens in isogenic mammalian cell lines without single cell cloning. Nat Commun. 2020;11:752.","journal-title":"Nat Commun"},{"key":"3970_CR12","doi-asserted-by":"crossref","unstructured":"Kabir S, Cidado J, Andersen C, Dick C, Lin PC, Mitros T, et al. The CUL5 ubiquitin ligase complex mediates resistance to CDK9 and MCL1 inhibitors in lung cancer cells. Elife. 2019;8:e44288.","DOI":"10.7554\/eLife.44288"},{"key":"3970_CR13","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/s41589-021-00858-8","volume":"17","author":"S Kostrhon","year":"2021","unstructured":"Kostrhon S, Prabu JR, Baek K, Horn-Ghetko D, von Gronau S, Klugel M, et al. CUL5-ARIH2 E3-E3 ubiquitin ligase structure reveals cullin-specific NEDD8 activation. Nat Chem Biol. 2021;17:1075\u201383.","journal-title":"Nat Chem Biol"},{"key":"3970_CR14","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.molcel.2021.01.014","volume":"81","author":"FV Hundley","year":"2021","unstructured":"Hundley FV, Sanvisens Delgado N, Marin HC, Carr KL, Tian R, Toczyski DP. A comprehensive phenotypic CRISPR-Cas9 screen of the ubiquitin pathway uncovers roles of ubiquitin ligases in mitosis. Mol Cell. 2021;81:1319\u201336.e1319.","journal-title":"Mol Cell"},{"key":"3970_CR15","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1158\/2159-8290.CD-20-1851","volume":"12","author":"S Lin","year":"2022","unstructured":"Lin S, Larrue C, Scheidegger NK, Seong BKA, Dharia NV, Kuljanin M, et al. An in vivo CRISPR screening platform for prioritizing therapeutic targets in AML. Cancer Discov. 2022;12:432\u201349.","journal-title":"Cancer Discov"},{"key":"3970_CR16","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/s41375-024-02178-x","volume":"38","author":"S Lin","year":"2024","unstructured":"Lin S, Schneider C, Su AH, Alexe G, Root DE, Stegmaier K. The UBE2J2\/UBE2K-MARCH5 ubiquitination machinery regulates apoptosis in response to venetoclax in acute myeloid leukemia. Leukemia. 2024;38:652\u20136.","journal-title":"Leukemia"},{"key":"3970_CR17","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/s41375-023-01879-z","volume":"37","author":"F Nakao","year":"2023","unstructured":"Nakao F, Setoguchi K, Semba Y, Yamauchi T, Nogami J, Sasaki K, et al. Targeting a mitochondrial E3 ubiquitin ligase complex to overcome AML cell-intrinsic Venetoclax resistance. Leukemia. 2023;37:1028\u201338.","journal-title":"Leukemia"},{"key":"3970_CR18","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1101\/gad.2056211","volume":"25","author":"L Zhang","year":"2011","unstructured":"Zhang L, Fairall L, Goult BT, Calkin AC, Hong C, Millard CJ, et al. The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor. Genes Dev. 2011;25:1262\u201374.","journal-title":"Genes Dev"},{"key":"3970_CR19","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1038\/s41591-019-0668-z","volume":"25","author":"S Khan","year":"2019","unstructured":"Khan S, Zhang X, Lv D, Zhang Q, He Y, Zhang P, et al. A selective BCL-X(L) PROTAC degrader achieves safe and potent antitumor activity. Nat Med. 2019;25:1938\u201347.","journal-title":"Nat Med"},{"key":"3970_CR20","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s42003-020-01328-y","volume":"3","author":"M Watanabe","year":"2020","unstructured":"Watanabe M, Saeki Y, Takahashi H, Ohtake F, Yoshida Y, Kasuga Y, et al. A substrate-trapping strategy to find E3 ubiquitin ligase substrates identifies Parkin and TRIM28 targets. Commun Biol. 2020;3:592.","journal-title":"Commun Biol"},{"key":"3970_CR21","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1128\/MCB.01716-12","volume":"33","author":"E Scotti","year":"2013","unstructured":"Scotti E, Calamai M, Goulbourne CN, Zhang L, Hong C, Lin RR, et al. IDOL stimulates clathrin-independent endocytosis and multivesicular body-mediated lysosomal degradation of the low-density lipoprotein receptor. Mol Cell Biol. 2013;33:1503\u201314.","journal-title":"Mol Cell Biol"},{"key":"3970_CR22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1126\/science.1168974","volume":"325","author":"N Zelcer","year":"2009","unstructured":"Zelcer N, Hong C, Boyadjian R, Tontonoz P. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science. 2009;325:100\u20134.","journal-title":"Science"},{"key":"3970_CR23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nm.4474","volume":"24","author":"ML Hyer","year":"2018","unstructured":"Hyer ML, Milhollen MA, Ciavarri J, Fleming P, Traore T, Sappal D, et al. A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment. Nat Med. 2018;24:186\u201393.","journal-title":"Nat Med"},{"key":"3970_CR24","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/j.cmet.2021.09.001","volume":"33","author":"Y Song","year":"2021","unstructured":"Song Y, Liu J, Zhao K, Gao L, Zhao J. Cholesterol-induced toxicity: an integrated view of the role of cholesterol in multiple diseases. Cell Metab. 2021;33:1911\u201325.","journal-title":"Cell Metab"},{"key":"3970_CR25","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1111\/cas.15349","volume":"113","author":"H Yano","year":"2022","unstructured":"Yano H, Fujiwara Y, Horlad H, Pan C, Kai K, Niino D, et al. Blocking cholesterol efflux mechanism is a potential target for antilymphoma therapy. Cancer Sci. 2022;113:2129\u201343.","journal-title":"Cancer Sci"},{"key":"3970_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2008.06.010","volume":"203","author":"G Lambert","year":"2009","unstructured":"Lambert G, Charlton F, Rye KA, Piper DE. Molecular basis of PCSK9 function. Atherosclerosis. 2009;203:1\u20137.","journal-title":"Atherosclerosis"},{"key":"3970_CR27","doi-asserted-by":"publisher","first-page":"S126","DOI":"10.1038\/sj.cdd.4401533","volume":"11","author":"A Szanto","year":"2004","unstructured":"Szanto A, Narkar V, Shen Q, Uray IP, Davies PJ, Nagy L. Retinoid X receptors: X-ploring their (patho)physiological functions. Cell Death Differ. 2004;11:S126\u2013143.","journal-title":"Cell Death Differ"},{"key":"3970_CR28","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.tem.2010.06.009","volume":"21","author":"P Lefebvre","year":"2010","unstructured":"Lefebvre P, Benomar Y, Staels B. Retinoid X receptors: common heterodimerization partners with distinct functions. Trends Endocrinol Metab. 2010;21:676\u201383.","journal-title":"Trends Endocrinol Metab"},{"key":"3970_CR29","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/ajh.25450","volume":"94","author":"F Maura","year":"2019","unstructured":"Maura F, Agnelli L, Leongamornlert D, Bolli N, Chan WC, Dodero A, et al. Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma. Am J Hematol. 2019;94:628\u201334.","journal-title":"Am J Hematol"},{"key":"3970_CR30","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the World Health Organization Classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36:1720\u201348.","journal-title":"Leukemia"},{"key":"3970_CR31","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1182\/blood.2023021786","volume":"144","author":"L de Leval","year":"2024","unstructured":"de Leval L, Gaulard P, Dogan A. A practical approach to the modern diagnosis and classification of T- and NK-cell lymphomas. Blood. 2024;144:1855\u201372.","journal-title":"Blood"},{"key":"3970_CR32","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1038\/s41375-025-02631-5","volume":"39","author":"Y Ito","year":"2025","unstructured":"Ito Y, Shimono J, Kawamoto K, Hatanaka KC, Kogure Y, Tabata M, et al. TP53 and CDKN2A alterations define a poor prognostic subgroup in patients with nodal T follicular helper cell lymphoma. Leukemia. 2025;39:1723\u201334.","journal-title":"Leukemia"},{"key":"3970_CR33","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s42255-019-0127-7","volume":"1","author":"SD Lee","year":"2019","unstructured":"Lee SD, Priest C, Bjursell M, Gao J, Arneson DV, Ahn IS, et al. IDOL regulates systemic energy balance through control of neuronal VLDLR expression. Nat Metab. 2019;1:1089\u2013100.","journal-title":"Nat Metab"},{"key":"3970_CR34","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/s42003-025-08200-x","volume":"8","author":"J Li","year":"2025","unstructured":"Li J, Li Z, Li X, Li Z, Song Y, Yuan L, et al. MYLIP attenuates hypoxia tolerance by inducing K27-linked polyubiquitination and subsequent proteasomal degradation of HIF-alpha. Commun Biol. 2025;8:774.","journal-title":"Commun Biol"},{"key":"3970_CR35","doi-asserted-by":"publisher","first-page":"19720","DOI":"10.1074\/jbc.M110.123729","volume":"285","author":"C Hong","year":"2010","unstructured":"Hong C, Duit S, Jalonen P, Out R, Scheer L, Sorrentino V, et al. The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2. J Biol Chem. 2010;285:19720\u20136.","journal-title":"J Biol Chem"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03970-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03970-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03970-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:47:55Z","timestamp":1791359275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03970-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":35,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2026,10,28]]}},"alternative-id":["3970"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03970-y","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M Nakagawa received research funding from AbbVie Pharmaceuticals. The other authors declare no competing financial interests related to this work.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. Animal experiments were approved by the Institutional Animal Care and Use Committee of Hokkaido University (approval No. 24-0126). The human data analyzed in this study were obtained from publicly available datasets, and no human participants were recruited for this study. Therefore, informed consent to participate was not applicable.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}